Far East Bio-Tec Co., Ltd.

6886 · TWO · Consumer Defensive / Packaged Foods

37.85TWD+1.05 (+2.85%)

Price History

Full chart

Market Stats

Previous Close36.80

Open36.80

Day Range36.80 – 37.85

52-Week Range38.44 – 46.44

Volume2.00K

Market Cap1.46B

P/E (TTM)23.37

Forward P/E0.00

EPS1.78

Dividend Yield1.20%

50-Day Avg41.88

200-Day Avg43.63

About

Far East Bio-Tec Co., Ltd. manufactures and sells organic chlorella, spirulina, and dietary supplements. It also offers nutraceuticals/nutritional supplements, immune booster products, antiviral sprays, and pet supplements. The company was founded in 1976 and is based in Taipei, Taiwan.

Company Details

SectorConsumer Defensive
IndustryPackaged Foods
CEOMr. C. C. Chiueh
HeadquartersRoom A, Taipei, Taiwan, 115, Taiwan
Websitehttps://www.febico.com

Leadership

Mr. C. C. ChiuehFounder & CEO

Financials

Income Statement

Currency: TWD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	292.67M	318.55M	379.73M	306.19M	387.74M	401.70M
Growth (%)	-	+8.84%	+19.21%	-19.37%	+26.63%	+3.60%
Cost of Revenue	156.42M	176.12M	165.04M	163.94M	200.81M	198.86M
Gross Profit	136.25M	142.44M	214.69M	142.24M	186.93M	202.84M
Gross Margin	46.55%	44.71%	56.54%	46.46%	48.21%	50.50%
Operating Expense	102.23M	102.82M	105.28M	113.69M	122.79M	134.24M
Operating Income	34.02M	39.62M	109.42M	28.55M	64.14M	68.60M
Operating Margin	11.62%	12.44%	28.81%	9.32%	16.54%	17.08%
EBITDA	54.90M	57.95M	126.63M	49.08M	90.29M	98.86M
EBITDA Margin	18.76%	18.19%	33.35%	16.03%	23.29%	24.61%
Net Income	39.76M	32.88M	90.66M	27.39M	52.49M	59.98M
Net Income Margin	13.59%	10.32%	23.88%	8.95%	13.54%	14.93%
R&D	34.86M	26.24M	25.03M	33.03M	23.86M	23.23M
R&D as % of Total Revenue	11.91%	8.24%	6.59%	10.79%	6.15%	5.78%
Interest Expense	610.00K	518.00K	526.00K	583.00K	1.21M	1.11M
Interest Expense % of Total Revenue	0.21%	0.16%	0.14%	0.19%	0.31%	0.28%

Balance Sheet

Currency: TWD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	486.27M	463.57M	545.75M	569.49M	641.30M	701.95M
Total Liabilities	95.88M	97.88M	114.24M	80.86M	127.50M	114.10M
Total Equity	388.16M	365.70M	431.51M	488.63M	513.79M	587.85M
Cash	271.37M	252.34M	295.96M	301.27M	275.25M	271.65M
Total Debt	51.85M	48.27M	47.63M	37.65M	68.77M	-
Net Debt	-219.52M	-204.07M	-248.34M	-263.62M	-206.48M	-

Cash Flow

Currency: TWD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	75.92M	53.68M	106.80M	-2.08M	76.94M	48.83M
Investing Cash Flow	-5.50M	-9.80M	-30.37M	-14.49M	-67.16M	-
Financing Cash Flow	-7.74M	-62.90M	-32.82M	21.23M	-35.80M	-
Capital Expenditure	9.98M	7.11M	11.22M	15.55M	87.12M	60.37M
Free Cash Flow	65.93M	46.57M	95.58M	-17.63M	-10.18M	-11.54M
Dividends Paid	-	-	25.00M	75.06M	27.80M	30.19M
FCF to OCF	86.85%	86.76%	89.49%	845.76%	-13.23%	-23.62%
Dividend Paid to FCF	-	-	26.16%	-425.65%	-273.08%	-261.73%

Key Statistics & Ratios

Market Cap1.46B

Enterprise Value1.22B

Trailing P/E23.37

Forward P/E0.00

Price / Sales3.30

Price / Book2.38

EPS1.78

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding34.99M

Shares Float0

Dividend Yield1.20%

Dividend Rate0.50

Payout Ratio51.02%

Dividends

20261×

0.50Aug 28, 2026

20251×

0.91Aug 13, 2025

20241×

0.87Aug 13, 2024

20231×

2.23Jul 12, 2023

Stock Splits

Aug 28, 20261100:1000
Aug 13, 20251049.8943:1000
Aug 13, 20241050:1000